V2 Financial group LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1,395.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,645 shares of the healthcare conglomerate’s stock after purchasing an additional 8,067 shares during the period. UnitedHealth Group comprises about 1.6% of V2 Financial group LLC’s investment portfolio, making the stock its 6th biggest holding. V2 Financial group LLC’s holdings in UnitedHealth Group were worth $2,697,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of UNH. LFA Lugano Financial Advisors SA acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $25,000. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Sagard Holdings Management Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $29,000. Islay Capital Management LLC bought a new position in UnitedHealth Group in the second quarter worth about $31,000. Finally, Riggs Asset Managment Co. Inc. grew its holdings in shares of UnitedHealth Group by 69.4% during the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 43 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
UNH has been the subject of a number of analyst reports. Bank of America boosted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Jefferies Financial Group lifted their price target on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday, October 17th. Finally, Barclays raised their target price on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Seventeen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Hold” and an average price target of $385.54.
UnitedHealth Group Stock Performance
UNH opened at $341.83 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The company has a market capitalization of $309.65 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. The business has a 50 day moving average price of $339.84 and a two-hundred day moving average price of $317.07. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the prior year, the firm posted $7.15 earnings per share. The company’s revenue was up 12.2% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- Most Volatile Stocks, What Investors Need to Know
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Amazon Could Be a $300 Stock Within Weeks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
